This POSTnote summarises some of the most important reasons behind the decline in clinical trials in the UK, and the actions being taken to improve the situation.Jump to full report >>
Clinical trials benefit the health and safety of patients by making proven new treatments available more quickly. This industry is also very important for the UK economy. However, recent years have seen a drop in the number of trials held in the UK. This POSTnote summarises some of the most important reasons behind this decline, and the actions being taken to improve the situation. It also highlights areas identified by key industry partners as opportunities for growth.
Author: Ana Padilla
The Parliamentary Office of Science and Technology produces independent, balanced and accessible briefings on public policy issues related to science and technology.